Cargando…
The development and validation of a clinical prediction model to determine the probability of MODY in patients with young-onset diabetes
AIMS/HYPOTHESIS: Diagnosing MODY is difficult. To date, selection for molecular genetic testing for MODY has used discrete cut-offs of limited clinical characteristics with varying sensitivity and specificity. We aimed to use multiple, weighted, clinical criteria to determine an individual’s probabi...
Autores principales: | Shields, B. M., McDonald, T. J., Ellard, S., Campbell, M. J., Hyde, C., Hattersley, A. T. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer-Verlag
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3328676/ https://www.ncbi.nlm.nih.gov/pubmed/22218698 http://dx.doi.org/10.1007/s00125-011-2418-8 |
Ejemplares similares
-
High-Sensitivity CRP Discriminates HNF1A-MODY From Other Subtypes of Diabetes
por: McDonald, Tim J., et al.
Publicado: (2011) -
A UK nationwide prospective study of treatment change in MODY: genetic subtype and clinical characteristics predict optimal glycaemic control after discontinuing insulin and metformin
por: Shepherd, Maggie H., et al.
Publicado: (2018) -
GCK gene mutations are a common cause of childhood‐onset MODY (maturity‐onset diabetes of the young) in Turkey
por: Haliloglu, Belma, et al.
Publicado: (2016) -
Syndromic monogenic diabetes genes should be tested in patients with a clinical suspicion of MODY
por: Colclough, Kevin, et al.
Publicado: (2022) -
Update on clinical screening of maturity-onset diabetes of the young (MODY)
por: Peixoto-Barbosa, Renata, et al.
Publicado: (2020)